Taegyun Yun

Taegyun Yun

Auto-generated profile, based on publicly available information

Taegyun Yun

Immunodiagnostics R&D Team, IVD Business Unit, New Business Division, SK telecom Co., Seongnam, Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2015 in BMC Genomics
Verified
Journal Article
Open access
PDF file
MKMin-Seok Kwon
Min-Seok Kwon
YKYongkang Kim
Yongkang Kim
SLSeungyeoun Lee
Seungyeoun Lee
JNJunghyun Namkung
Junghyun Namkung
TYTaegyun Yun
Taegyun Yun
Taesung ParkTaesung Park
Taesung Park
MicroRNA (miRNA) expression plays an influential role in cancer classification and malignancy, and miRNAs are feasible as alternative diagnostic markers for pancreatic cancer, a highly aggressive neoplasm with silent early symptoms, high metastatic potential, and resistance to conventional therapies. In this study, we evaluated the benefits of multi-omics data analysis by integrating miRNA and mRNA expression data in pancreatic cancer. Using support vector machine (SVM) modelling and leave-one-out cross validation (LOOCV), we evaluated the diagnostic performance of single- or multi-markers based on miRNA and mRNA expression profiles from 104 PDAC tissues and 17 benign pancreatic tissues. For selecting even more reliable and robust markers, we performed validation by independent datasets from the Gene Expression Omnibus (GEO) and the Cancer Genome Atlas (TCGA) data depositories. For validation, miRNA activity was estimated by miRNA-target gene interaction and mRNA expression datasets in pancreatic cancer. Using a comprehensive identification approach, we successfully identified 705 multi-markers having powerful diagnostic performance for PDAC. In addition, these marker candidates annotated with cancer pathways using gene ontology analysis. Our prediction models have strong potential for the diagnosis of pancreatic cancer.